Pentadecapeptide BPC 157 positively affects both non-steroidal anti-inflammatory agent-induced gastrointestinal lesions and adjuvant arthritis in rats

Journal of Physiology Paris

Volumn 91, Issue 3-5, 1997, Pages 113-122

  Sikiric, P ^a   Seiwerth, S ^a   Grabarevic, Z ^a   Rucman, R ^a   Petek, M ^a   Jagic, V ^a   Turkovic, B ^a   Rotkvic, I ^a   Mise, S ^a   Zoricic, I ^a   Konjevoda, P ^a   Perovic, D ^a   Simicevic, V ^a   Separovic, J ^a   Hanzevacki, M ^a   Ljubanovic, D ^a   Artukovic, B ^a   Bratulic, M ^a   Tisljar, M ^a   Rekic, B ^a   Gjurasin, M ^a   Miklic, P ^a   Buljat, G ^a   more..

^a UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

Adjuvant arthritis; Gastroentestinal lesions; Pentadecapeptide BPC 157; Peptide BPC

Indexed keywords

ACETYLSALICYLIC ACID; DICLOFENAC; GLYCYLGLUTAMYLPROLYLPROLYLPROLYLGLYCYLLYSYLPROLYLALANYLASPARTYLASPARTYLALANYLGLYCYLLEUCYLVALINE; INDOMETACIN; UNCLASSIFIED DRUG;

ADJUVANT ARTHRITIS; ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; DIGESTIVE SYSTEM INJURY; DIGESTIVE SYSTEM ULCER; DRUG EFFECT; FEMALE; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; RAT; STOMACH JUICE;

EID: 0030710170     PISSN: 09284257     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-4257(97)89474-0     Document Type: Conference Paper

References (50)

1. Banic M, Brkic T, Anic B, Rotkvic I, Grabarevic Z, Duvnjak M, Troskot B, Mihatov S (1993) Effect of methylprednisolone on small bowel, spleen and liver changes in a murine model of inflammatory bowel disease. Aliment Pharmacol Ther 7, 201-206
2. Bosnjak ZJ, Graf BM, Sikiric P, Stowe DF (1994) Protective effects of newly isolated gastric peptide following hypoxic and reoxygenation injury in the isolated guinea pig heart. FASEB J 8, A 129
3. Brkic T, Banic M, Anic B, Grabarevic Z, Rotkvic I, Artukovic B, Duvnjak M, Sikiric P, Troskot B, Hernandez DE (1992a) A model of inflammatory bowel disease induced by 2,4-dintirofluorobenzene in previously sensitized BALB-c mice. Scand J Gastroenterol 27, 184-188
4. Brkic T, Banic M, Anic B, Rotkvic I, Grabarevic Z, Sikiric P, Duvnjak M, Krpan H, Maric S, Kovacevic I (1992b) The influence of methylprednisolone on inflammatory bowel lesions induced with 2,4-dinitrofluorobenzene in previously sensitized BALB-c mice. Exp Clin Gastroenterol 2, 361-364
5. Brown JH, Taylor JL, Pollock SH (1971) Effect of duration of administration of cyclophosphamide and steroidal anti-inflammatory drugs on the severity of polyathritis. Arch Int Pharmacodyn 194, 381-386
6. Caruso I, Bianchi Porro G (1980) Gastroscopic evaluation of anti-inflammatory agents. Br Med J 280, 75-78
7. Damas J, Deflandre E (1984) The mechanism of the anti-inflammatory effect of turpentine in the rat. Naunyn-Schmiedeberg's Arch Pharmacol 327, 143-147
8. Doherty M, Hunt RH, Langman MJ (1987) Management of NSAID-induced gastrointestinal disturbance. Ann Rheum Dis 46, 640-643
9. Festen HPM (1988), Diagnosis of gastrointestinal lesions during treatment with non-steroidal anti-inflammatory drugs. Aliment Pharmacol Therap 2S, 113-109
10. Glenn EM, Grey J (1965) Adjuvant-induced polyarthritis in rats. Am J Vet Res 26, 1180-1194
11. Guglietta A (1992) Possible clinical use of peptide growth factors in the GI tract: perspectives and obstacles. Exp Clin Gastroenterol 3, 1-6
12. Gyires K, Torma Z (1984) The use of the writhing in mice for screening different types of analgesics. Arch Int Pharmacodyn Ther 267, 131-140
13. Hernandez DE, Adcock JW, Nemeroff CB, Prange AJ (1984) The role of adrenal gland in cytoprotection against stress induced gastric ulcers in rats. J Neurosci Res 11, 193-201
14. Holzer P (1991) Peptidergic sensory neurons in the control of vascular functions: Mechanisms and signficance in the cutaneous and splanchnic vascular beds. Rev Physiol Biochem Pharmacol 121, 49-146
15. Kuwayama H, Eastwood GL (1985) Effect of water immersion restraint stress and chronic indomethacin ingestion gastric antral and fundic epithelial proliferation. Gastroenterology 88, 362-365
16. Malone DG, Vikingsson A, Seebruch JS, Verbsky JW, Dolan PW (1991) In vivo effects of nonsteroidal anti-inflammatory drugs on rat skin and synovial mast cell-induced vasopermeability. Arthritis Rheumatism 34, 164-170
17. Mantyh PW (1991) Substance P and the inflammatory and immune response. Ann NY Acad Sci 632, 263-271
18. Marabini S, Matucci-Cerinic M, Geppetti P, Del Bianco E, Marchesoni A, Tosi S, Cagnoni M, Partsch G (1991) Substance P and somatostatin levels in rheumatic arthritis, ostearthritis, and psoriatic arthritis synovial fluid. Ann NY Acad Sci 632, 435-436
19. Morris GP, Rebeira L, Herridge MM, Szewczuk M, Depw W (1984) An animal model for chronic granulomatous inflammation of the stomach and the colon. Gastroenterology 86, 1188.
20. Newbould BB (1963) Chemotherapy of arthrititis induced in rats by mycobacterial adjuvant. Br J Pharmacol 21, 127-136
21. Paré W, Klucyznski JM (1994) The effect of new gastric juice peptide BPC on classic stress triad in stress procedure. Exp Clin Gastroenterol 2, 234-236
22. Pearson CM (1956) Development of arthritis, periarthritis and periostitis in rats given adjuvants. Proc Soc Exp Biol (NY) 91, 95-101
23. Pearson CM (1959) Development of arthritis in the rat following injection with adjuvant. In: Mechanisms of Hypersensitivity. Little Brown, Boston, 647-671
24. Perper RJ, Alvarez B, Colomvbo C, Schroder A (1971) The use of a standardized adjuvant arthitis assay to diffeerentiate between anti-inflammatory and immunosuppressive agents. Proc Soc Exp Biol Med (NY) 137, 506-512
25. Rainsford KD (1992). Mechanisms of NSAID-induced ulcerogenesis: structural properties of drugs, focus on the microvascular factors, and novel approaches for gastro-intestinal protection. In: Cell injury and protection in the gastrointestinal tract: from basic sciences to clinical perspectives. Akedémiai Kiadó. Budapest, 23-38
26. Robert A (1979) Cytoptotection by prostaglandins. Gastroenterology 77, 761-767
27. Robert A, Lancaster C, Olafsson AS, Gilbertson-Beadling S, Zhang W (1991) Gastric adaptation to the ulcerogenic effect of aspirin. Exp Clin Gastroenterol 1, 73-81
28. Rooney PJ, Dick WC, Imrie RC, Buchanan KD (1973a) Animal model to study the relationship between immunoreactive gastrin and inflammatory arthritis. Nature 246, 497-498
29. Rooney PJ, Vince J, Kennedy AC, Webb J, Lee P, Dick WC, Buchanan KD, Hayes JR, Ardill J, O'Connor F (1973b) Hypergastrinemia in rheumatoid arthritis: disease or iatrogenesis. Br Med J 2, 752-753
30. Sandor Z, Vincze A, Szabo S (1996) The protective effect of a recently isolated gastric peptide in acute and chronic gastroduodenal injury. FASEB J 10, 171
31. Shen TY (1977) Chemical and biological studies on indomethacin, sulindac and their analogs. Adv Drug Res 12, 89-245
32. Shen TY (1984) The proliferation of non-steroidal anti-inflammatory drugs (NSAIDS). In: Discoveries in pharmacology, Volume 2: Haemodynamics, hormones & inflammation. Elsevier Science Publishers BV, Amsterdam, New York, Oxford, 523-553
33. Sikiric P, Rotkvic I, Mise S, Krizanac S, Gjuris V, Jukic J, Suchanek E, Petek M, Udovicic I, Kalogjera L, Geber J, Tucan-Foretic M, Duvnjak M, Philipp M, Balen I, Anic T (1988) The influence of dopamine agonists and antagonists on indomethacin lesions in stomach and small intestine in rats. Eur J Pharmacol 158, 61-67
34. Sikiric P, Banic M, Brkic T, Seiwerth S, Grabarevic Z, Rucman R, Petek M, Anic B, Rotkvic I, Duvnjak M Veljaca M, Simicevic V (1993a) Effect of a novel pentadecapeptide BPC 157 and rnethylprednisolone in a murine model of inflammatory bowel disease. Gastroenterology 104, 782
35. Sikiric P, Gyires K, Seiwerth S, Grabarevic Z, Rucman R, Petek M, Rotkvic I, Turkovic B, Udovicic I, Jagic V, Mildner B, Duvnjak M, Danilovic Z (1993b) The effect of pentadecapeptide BPC 157 on inflammatory, non-inflammatory, direct and indirect pain and capsaicin neurotoxicity. Inflammopharmacology 2, 121-127
36. Sikiric P, Petek M, Rucman R, Seiwerth S, Grabarevic Z, Rotkvic I, Jagic V, Mildner B, Duvnjak M, Lang N (1993c) A new gastric juice peptide, BPC-an overview of stomach/stress/organoprotection hypothesis and BPC beneficial effects. J Physiol (Paris) 87, 313-327
37. 4 administration. A comparative study with dopamine agonists and somatostatin. Life Sci 53, PL291-PL297
38. Sikiric P, Seiwerth S, Grabarevic Z, Rucman R, Petek M, Rotkvic I, Turkovic B, Jagic V, Mildner B, Duvnjak M, Danilovic Z (1994) The beneficial effect of BPC 157, a 15 amino acid peptide BPC fragment, on gastric and dudodenal lesions induced by restraint stress, cysteamine and 96% ethanol in rats. A comparative study with H2 receptor antagonists, dopamine promoters and gut peptides. Life Sci 54, PL63-PL69
39. Sikiric P, Rotkvic I, Mise S, Seiwerth S, Grabarevic Z, Petek M, Rucman R, Zjacic-Rotkvic V, Duvnjak M, Jagic V, Suchanek E, Marovic A, Banic M, Brkic T, Hanzevacki M, Separovic J, Djacic S, Simicevic V (1995) Dopamine agents efficacy in peptic ulcer healing and relapse prevention - a further indication for importance of stomach dopamine in the stress organoprotection concept. In: Neuroendocrinology of Gastrointestinal Ulceration. Hans Selye Symposia on Neuroendocrinology and Stress. Volume 2. Plenum Publishing Corporation, New York, 221-230
40. Sikiric P, Seiwerth S, Grabarevic Z, Rucman R, Petek M, Jagic V, Turkovic B, Rotkvic I, Mise S, Zoricic I, Jurina Lj, Konjevoda P, Hanzevacki M, Ljubanovic D, Separovic J, Gjurasin M, Bratulic M, Artukovic B, Jelovac N, Buljat G (1996a) Salutary and prophylactic effect of pentadecapeptide BPC 157 on acute pancreatitis and concomitant gastroduodenal lesions in rats. Dig Dis Sci 41, 1518-1526
41. Sikiric P, Seiwerth S, Grabarevic Z, Rucman R, Petek M, Jagic V, Turkovic B, Rotkvic I, Mise S, Zoricic I, Gjurasin M, Konjevoda P, Separovic J, Ljubanovic D, Artukovic B, Bratulic M, Tisljar M, Jurina Lj, Buljat G, Miklic P, Marovic A (1996b) The beneficial effect of a novel pentadecapeptiide BPC 157 on gastric lesions induced by restraint stress, ethanol, indomethacin and capsaicin neurotoxicity. Dig Dis Sci 41, 1604-1614
42. Tascilar O, Saray A, Dizbay-Sak S, Melli M (1993) Acetylsalicylic acid and misoprostol combination in adjuvant arthritis of rats. Inflammation 17, 489-498
43. Thompson J, Greeley GH Jr, Rayford PL, Twonsed CM Jr (1987) Gastrointestinal endocrinology. McGraw-Hill Book Company, New York
44. Veljaca M, Lech CA, Pllana R, Sanchez B, Chan K, Guglietta A (1994a) BPC-15 reduces trinitrobenzene sulfonic acid-induced colonic damage in rats. J Pharmacol Exp Ther 272, 417-422
45. Veljaca M, Pllana R, Lech CA, Sanchez B, Chan K, Guglietta A (1994b) Protective effect of BPC 157 on a rat model of colitis. Gastroenterology 106, 789
46. Veljaca M, Chan K, Guglietta A (1995a) Digestion of h-EGF, h-TGF alpha, and BPC-15 in human gastric juice. Gastroenterology 108, 761
47. Veljaca M, Lech CA, Sanchez B, Low J, Guglietta A (1995b) Protection of BPC-15 on TNBS-induced colitis in rats: possible mechanisms of action. Gastroenterology 108, 936
48. Willoughby SG, Hopps RM, Johanson NW (1962) Carrageenin-induced oedema in hind paw of the rat as an assay for anti-inflammatory drugs. Proc Soc Exp Biol Med (NY) 111, 544-547
49. Willoughby SG, Hopps RM, Johanson NW (1986) Changes in the rate of epithelial proliferation of rat mucosa in response to acute inflammation induced by turpentine. Archs Oral Biol 31, 193-199
50. Winter CA, Risely EA, Nuss GW (1962) Carrageenin-induced oedema in hind paw of the rat as an assay for anti-inflammatory drugs. Proc Soc Exp Biol Med 111, 544